Description:
Brexpiprazole is a novel atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.
- Molecular Weight: 433.58
- Molecular Formula: C25H27N3O2S
Purity: > 95%
Canonical SMILES:
C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4
InChI:
InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)
InChIKey: ZKIAIYBUSXZPLP-UHFFFAOYSA-N
- Boiling Point: 675.2±55.0 °C | Condition: Press: 760 Torr
- Solubility: DMSO: ≥ 48 mg/mL
- Appearance: White Solid
- Application: Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for depression. It is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.
- Storage: -20°C Freezer
Synonyms:
7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one; OPC 34712
More details are to be found on supplier website
